Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and toxicity of pemetrexed and docetaxel
administered on a 3-weekly schedule in the treatment of patients with locally advanced or
metastatic non-small cell lung cancer (NSCLC) who have had prior chemotherapy.